Jonathan P. Foster, Chief Financial Officer at Moleculin Biotech, Inc. (MBRX), bought 547,579 shares at $0.37 ($200K) on 2025-06-23, disclosed to the SEC on 2025-06-23.
Seasonal purchase ($200k) by Chief Financial Officer — this insider has traded MBRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,711 | $0 | 0.0% |
| 2 | $0.00 | 4,328 | $0 | 0.0% |
| 3 | $0.37 | 270,270 | $100K | 50.0% |
| 4 | $0.37 | 270,270 | $100K | 50.0% |
| Total | $0.37 avg | 547,579 | $200K | 100% |
| Filing → |
| INFU | BUY | 2015-08-18 | $3K | — | Filing → |
| INFU | BUY | 2015-06-17 | $973 | — | Filing → |
| INFU | BUY | 2015-05-18 | $13K | — | Filing → |